Author(s)

Ismail Hakki Korucu^1*, Faik Turkmen¹, Burkay Kacira¹, Onur Bilge¹, Alper Kilicaslan², Serdar Toker¹

¹Orthopaedic and Traumatology Department, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
²Anesthesiology Department, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.

Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) are major surgical procedures which can cause high morbidity and even mortality. Among these complications is venous thrombo embolism (VTE) comprising deep vien thrombosis (DVT) and pulmonary embolism (PE). Therefore, after these operations, thromboprophylaxis is routinely used. However, it has some complications such as bleeding, adverse effect of chemical agents for using prevention of DVT. Anti-thrombotic prophylaxis includes: low molecular weight heparin (LMWH), fondaparinux, apixaban, dabigatran, rivaroxaban, low dose unfractionated heparin (LDUH), adjusted dose vitamin K antagonist (VKA), aspirin, or mechanical thromboprophylaxis devices. All over the World, orthopaedic surgeons consider a balance between thromboprophylaxis and bleeding. However, it has been still controversy about optimum prophylaxis for DVT. In this current paper, we aimed to review the literature under light of the current studies.

Total Hip Arthroplasty, Total Knee Arthroplasty, Thromboprophylaxis

Korucu, I. , Turkmen, F. , Kacira, B. , Bilge, O. , Kilicaslan, A. and Toker, S. (2014) Thromboprophylaxis for Hip and Knee Arthroplasty: Current Managements and Review of the Literature. World Journal of Cardiovascular Diseases, 4, 586-593. doi: 10.4236/wjcd.2014.412071.